Back
ProShares Ultra MSCI Emg Mkts Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
69
EET
ProShares Ultra MSCI Emg Mkts
Last Price:
$79.01
Seasonality Move:
3.97%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.99
Seasonality Move:
-31.39%
Buy
69
ProShares Ultra MSCI Emg Mkts (EET)
is a Buy
Is ProShares Ultra MSCI Emg Mkts a Buy, Sell or Hold?
-
The current ProShares Ultra MSCI Emg Mkts [EET] share price is $78.83. The Score for EET is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
EET is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EET Stock Price Chart
What is ProShares Ultra MSCI Emg Mkts's stock price today?
-
The ProShares Ultra MSCI Emg Mkts share price today is $78.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EET is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
EET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 52 | Buy |
| Chaikin Money Flow: | -16536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.75 - 80.85) | Buy |
| Bollinger Bands (100): | (68.51 - 79.85) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.48 | Buy |
| Relative Strength Index (14 RSI): | 86.01 | Buy |
| Chaikin Money Flow: | 124529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 42.89) | Buy |
| Bollinger Bands (100): | (18.11 - 33.75) | Buy |
EET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.31 | Buy |
| 20-day SMA: | 78.42 | Buy |
| 50-day SMA: | 78.9 | Sell |
| 200-day SMA: | 65.49 | Buy |
| 8-day EMA: | 78.31 | Buy |
| 20-day EMA: | 78.38 | Buy |
| 50-day EMA: | 77.59 | Buy |
| 200-day EMA: | 68.5 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.44 | Buy |
| 50-day SMA: | 32.1 | Buy |
| 200-day SMA: | 23.71 | Buy |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 32.59 | Buy |
| 200-day EMA: | 27.3 | Buy |
ProShares Ultra MSCI Emg Mkts Earnings Growth & EET Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.
ProShares Ultra MSCI Emg Mkts Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||